RhumbLine Advisers’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $12.5M | Buy |
|
|||||
|
2025
Q2 | $7.98M | Sell |
|
|||||
|
2025
Q1 | $8.73M | Buy |
|
|||||
|
2024
Q4 | $7.54M | Buy |
|
|||||
|
2024
Q3 | $5.14M | Sell |
|
|||||
|
2024
Q2 | $7.1M | Buy |
|
|||||
|
2024
Q1 | $5.65M | Buy |
|
|||||
|
2023
Q4 | $4.77M | Buy |
|
|||||
|
2023
Q3 | $2.81M | Buy |
|
|||||
|
2023
Q2 | $4.35M | Buy |
|
|||||
|
2023
Q1 | $4.24M | Buy |
|
|||||
|
2022
Q4 | $5.03M | Buy |
|
|||||
|
2022
Q3 | $1.06M | Buy |
|
|||||
|
2022
Q2 | $1.1M | Buy |
|
|||||
|
2022
Q1 | $1.22M | Buy |
|
|||||
|
2021
Q4 | $1.01M | Sell |
|
|||||
|
2021
Q3 | $966K | Buy |
|
|||||
|
2021
Q2 | $1.16M | Buy |
|
|||||
|
2021
Q1 | $1.22M | Sell |
|
|||||
|
2020
Q4 | $1.26M | Buy |
|
|||||
|
2020
Q3 | $1.32M | Sell |
|
|||||
|
2020
Q2 | $1.53M | Buy |
|
|||||
|
2020
Q1 | $767K | Buy |
|
|||||
|
2019
Q4 | $982K | Buy |
|
|||||
|
2019
Q3 | $877K | Buy |
|
|||||
|
2019
Q2 | $1.06M | Buy |
|
|||||
|
2019
Q1 | $1.14M | Sell |
|
|||||
|
2018
Q4 | $1.05M | Buy |
|
|||||
|
2018
Q3 | $1.31M | Buy |
|
|||||
|
2018
Q2 | $1.59M | Buy |
|
|||||
|
2018
Q1 | $484K | Buy |
|
|||||
|
2017
Q4 | $307K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $22K | Hold |
|
|||||
|
2015
Q4 | $32K | Buy |
|
|||||
|
2015
Q3 | $141K | Buy |
|
|||||
|
2015
Q2 | $175K | Buy |
|
|||||
|
2015
Q1 | $126K | Buy |
|
|||||
|
2014
Q4 | $139K | Buy |
|
|||||
|
2014
Q3 | $153K | Buy |
|
|||||
|
2014
Q2 | $206K | Buy |
|
|||||
|
2014
Q1 | $170K | Sell |
|
|||||
|
2013
Q4 | $213K | Hold |
|
|||||
|
2013
Q3 | $256K | Sell |
|
|||||
|
2013
Q2 | $204K | Buy |
|